Emotional health is the panacea for a wise America.

Emotional intelligence comes from emotional health.

Wisdom Education is Brain Health Education; Where Wisdom Land is a Start...

Our Education System Has Cutting Edge Mind Education While Brain Education Is Under the radar Screen.

Know the Level of Your brain You Are Living From.

Know and Harness the Difference Between Your Brain and Mind.

All this stress, anxiety, restlessness, sleeplessness, greed, hatred, & the other attributes of our basic animal nature are due to the belief of being the best.

The key to everything great in our world is to create a massive drive to change/heal our habitual self/group/country-image from selfishness to selflessness. From egoistic to humble.”

— Sajid Khan,


Our country is dived into two camps. Our world is divided into many camps. Our society is divided into four classes of people. It all boils down to the fact that ignorance is sucking out and destroying all the wisdom that can provide the magic sauce for equality and justice for all. Ignorance is vandalizing wisdom which is the key to justice and equality.

When it comes to wisdom there is no discrimination for class, race, region or gender. As long as the magic sauce of wisdom is missing from the lives of individuals, groups and countries there will always be injustice, inequality, hate, exploitation, sickness, poverty, sleeplessness, unhappiness. All these ills of society for individuals, groups and countries are the consequences of letting the world remain as unwise as ever.

Wisdom is not just about morals and ethics, wisdom is about health. The current world order is based on lack of wisdom. The world, our leaders, and our experts are blind to the fact that wisdom is the panacea to a just world. The first step is to remove the ignorance regarding wisdom by defining wisdom not by what it is but by whatever generates wisdom. Wisdom is generated by emotional health. Emotional health is wisdom and wisdom is emotional health.

Emotional health is generated by an emotionally healthy brain. Thus to create wisdom, create emotional health. Emotional health is generated by humility. Humility is nothing but selflessness. So wisdom boils down to how groups, countries and individuals answer the question, 'Who am I?'. Currently in America we are all brought up to be mind/brain conditioned to being the best. With this one folly we throw wisdom out of the equation of life. With this one blunder we block out wisdom along with its attributes from ourselves. From the drug addictions to all other addictions are a direct result of this faulty upbringing.

We will have to create new upbringing guidelines. We will have to recognize that implanting the, 'I am the best' belief in our children is the biggest of all evils that we commit. We do not even have to consciously plant the feeling of humility. We need to create, 'Ultimate Humility' which is humility that is generated unconsciously without effort by creating/healing the selfish self-image into humility. Focus has to shift from teaching wisdom to healing the self-image into selflessness.

The wisest person in the world was Moses. It is no coincidence that he was also the humblest person ever. In fact when the nation of Israel was being created God gave humility to 70 future leaders of Israel. So humility is the key to a happy, prosperous, healthy and peaceful life. Humility is the defining factor of all great leadership.

Effortless Wisdom! Authentic Wisdom Is generated without effort unconsciously! The new world order has to be based on Emotional Health which is generated by humility.

All this stress, anxiety, restlessness, sleeplessness, greed, jealousy, hatred and all the other attributes of our basic animal nature are due to the belief of being the best.

We must start a compulsory course for all parents to ensure effortless wisdom threw effortless humility.

To teach wisdom, moral values, ethics etc. just take away the belief of being the best and make the person selfless. It is all about replacing selfishness with selflessness. It is all about healing the ego into selflessness.


We can make creating wisdom simple and clear cut through easy to follow and implement Emotional Health Apps. We need a genuine conference at the UN on wisdom. We also need a documentary and a world anthem on wisdom.

Related articles:



Sajid Khan, President
4th R Foundation
+1 201-450-8098
email us here
Visit us on social media:

All emotions, including wisdom and love etc can now be defined in numbers. The art of living is now a science. Wisdom is a science!

Source: EIN Presswire

Cost of Future Medical Care: Defense and Plaintiff Attorney’s Dilemma

Dr. Greg Vigna

Dr. Greg Vigna

What are the ramifications of the Cuevas and Corenbaum decisions as to the evidence a jury may consider in determination of cost of future medical care?

MODESTO, CALIFORNIA, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Plaintiff and Defense attorneys in personal injury cases in California are trying to understand the ramifications of the Cuevas decision and Corenbaum decision as to what evidence the jury will be allowed to consider in their determination of the cost of future medical care.

The basic tenant of damages in the tort system will not be circumvented by legal decisions into the future in that an injured plaintiff will be compensate for their losses and payment for these losses will be paid by the party responsible. The admissibility of the evidence that is allowed to assist the jury in determination the actual cost of the damages is in flux.

The Cuevas Court in a medical malpractice case allowed for evidence of discounted future medical costs based on medical rates under the Affordable Care Act to the benefit of Defendant medical providers and to the detriment of the injured Plaintiff. The Sanchez Court would preclude this testimony as the cost of services would be derived from the fee schedule under the Affordable Care Act and this evidence might be considered hearsay. The Howell Court ruled that the cost of past medical damages is not admissible evidence as it relates to future medical care as past medical bills were ‘often too inflated to be meaningful’. This is in contrast to the Corenbaum Court decision that allowed for billed amounts of previous medical care to be admissible as evidence of cost of future care.

The above decisions leave uncertainty for both Defense and Plaintiff Attorneys who desire certainty in cases that are destined for trial. Academic Physician Life Care Planning, LLC utilizes experts in Physical Medicine and Rehabilitation, Orthopedic Surgeons, Interventional Pain Physicians, and Neurosurgeons who independently from the skill, knowledge, experience, and training are qualified under the Daubert standard to testify as to ‘reasonableness of cost of previous care’ and the ‘cost of future care’ because they do so on a daily basis in their own practice and through their ownership of facilities that provide such services.

Greg Vigna, MD, JD, a Certified Life Care Planner, and owner of Academic Physician Life Care Planning, LLC, understands the conflicting legal arguments and recommends attorneys to focus on the selection of the testifying experts the above conflicting decisions will have no effect on admissibility of opinion testimony as to the cost of necessity and appropriate care to the patient’s life expectancy from a physician who provides such care as part of their private practice. Academic Physician Life Care Planning, LLC provides these opinions from physicians when necessary from multiple specialties in its life care plans for no additional cost to Defendant and Plaintiff attorneys.

Greg Vigna
Academic Physician Life Care Planning
+1 800-761-9206
email us here

Source: EIN Presswire

Bacterial Pneumonia Far More Dangerous to the Heart Than Viral Pneumonia, Study Find

Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research

Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research.

SALT LAKE CITY, UTAH, USA, November 15, 2018 /EINPresswire.com/ — Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.

In the study of nearly 5,000 patients, researchers found that patients diagnosed with bacterial pneumonia had a 60 percent greater risk of a heart attack, stroke, or death than patients who had been diagnosed with viral pneumonia.

“We’ve always known pneumonia was a risk factor for a major adverse cardiac event, like a heart attack, within the first 90 days of being diagnosed,” said J. Brent Muhlestein, MD, a cardiovascular researcher with the Intermountain Medical Center Heart Institute. “What we didn’t know was which type of pneumonia was more dangerous. The results of this study provided a clear answer, which will allow physicians to better monitor patients and focus on reducing their risk of a major adverse cardiac event.”

Results of the study were presented at the the American Heart Association Scientific Sessions in Chicago.

The study evaluated 4,792 patients diagnosed with pneumonia who were hospitalized at one of Intermountain Healthcare’s 23 hospitals between January 2007 and May 2014. Each patient was followed for 90 days and tracked for non-fatal heart attacks, stroke, heart failure, or death.

Nearly 80 percent of the patients were diagnosed with bacterial pneumonia, and 34 percent (1,270 patients) of them had a major cardiovascular event within 90 days. At the same time, 21 percent of the patients were diagnosed with viral pneumonia, and 26 percent (258 patients) had a major adverse event within the 90-day window.

“The likely underlying cause is that bacterial pneumonia causes greater inflammation of the arteries compared to viral pneumonia,” said Dr. Muhlestein.

When arteries become inflamed, it destabilizes the layers of plaque that have built up over the years. The unstable plaque can then break loose from the artery wall and cause a blockage, which leads to a heart attack, stroke, or death.

“The practical result of our study is that caregivers should be aware of the greater cardiovascular risks associated with respiratory infections like pneumonia, and especially bacterial pneumonia,” said Dr. Muhlestein. “If a patient has been diagnosed with bacterial pneumonia, treat it aggressively and watch them closely for any signs of a heart attack or stroke. If the patient is taking medications specific to a heart condition, like high blood pressure or cholesterol, they should continue taking those prescribed medications.”

People with known plaque buildup should be especially mindful of things they can do to prevent respiratory infections. Dr. Muhlestein recommends getting a flu shot, a pneumovax, practicing proper hand hygiene year-round (and especially during cold and flu season), and quitting smoking immediately.

The Intermountain Heart Institute at Intermountain Medical Center is part of the Intermountain Healthcare system based in Salt Lake City.

Members of the research team involved in the study include Glendon Scott Steiner; Stacey Knight, PhD; Russell R. Miller III, MD; Tami L. Bair, RN; Benjamin Horne, PhD; Bert Lopansri, MD; Jeffrey L Anderson, MD; John F. Carlquist, PhD; and J. Brent Muhlestein, MD.

Jess Gomez
Intermountain Medical Center
email us here

Source: EIN Presswire

myStrength’s Evidence-Based, Non-Opioid Approach to Chronic Pain Helps Stem Opioid Use by Nearly 50%

The Opioid Crisis: myStrength Offers Hope and Help for Recovery

RCT Preliminary Findings Show Digital Behavioral Healthcare Tools Significantly Reduce Opioid Use

This work is so encouraging. This provides evidence-based support for adding myStrength’s digital behavioral self-care to chronic pain management protocols.”

— Dr. Abigail Hirsch, myStrength’s Chief Clinical Officer

DENVER, CO, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Chronic pain and subsequent opioid addiction in America remain at epidemic levels. Studies show only about one in five people in need of substance use treatment receive care.1

While much focus is being applied to stemming the flow of opioid-based medications into our healthcare system, few scalable resources are currently available to help the American healthcare consumer understand the appropriate role for such medications – and the breadth of alternative approaches for pain management.

myStrength is proud to introduce expansive new resources to support prevention, treatment and recovery from opioid use disorders (OUDs). This expansion is made in conjunction with groundbreaking preliminary results from a recent Pain Management Randomized Controlled Trial (RCT).

myStrength’s evidence-based, self-care tools inform individuals about opioid use disorders and the recovery process, and offer robust, alternative strategies to opioids and other substances, including the risks of continued use. The comprehensive Opioid Recovery Program emphasizes science-based, proven treatment options – particularly, medication-assisted treatment (MAT

The 36 diverse new Opioid Recovery activities feature interactive, multi-media, personalized activities that educate individuals about treatment options that promote successful recovery. As part of the expansion, myStrength developed interactive resources featuring peers in recovery, as well as addiction specialists. Relatable, evidence-based content and self-care tools help individuals manage their decisions and understand they are not alone in their journey. Topics include treatment options, why treatment works, what is involved and what to expect, inspiration from others who have succeeded in their recovery, and new recovery skills. The content is applicable to a broad audience, including those who are questioning their opioid use, worried about a loved one or already engaged in treatment.

These new OUD resources are a significant addition to myStrength’s whole-person support, which includes management of existing substance use disorders (SUDs), and comorbid conditions like depression, anxiety, stress, and sleep issues – all of which can amplify substance use challenges and addictive behaviors. Adding myStrength into recovery care models elevates individuals as active partners to their care team in these complicated and highly-personal decisions. myStrength is available 24/7 through payers and providers and can be accessed from any mobile device or computer, even at a public library.

The RCT looked at the impact of myStrength, a digital behavioral health platform for chronic pain management, as well as depression, anxiety, insomnia, stress and substance use disorders (among other conditions), compared to treatment as usual. Trial participants with chronic pain were assessed at baseline, 14 days, four weeks, and eight weeks. Intervention condition participants were re-assessed at six months. Control participants were offered the program at eight weeks and re-assessed one month later.

Pain functioning was assessed with the Global Pain Scale (GPS). Need for medication was assessed with an average of a need for medication question on the GPS and the Opioid Misuse Scale.

The RCT results were accepted for presentation at ISPOR Europe 2018 in Barcelona, Spain, November 10-14.

Short-term results from the Active Participant Group had significantly lower GPS (better functioning) than other groups at 14 days and four weeks. Active participants also indicated less need for medication at 14 days and four weeks. Statistical modeling indicates that active participants reduced their self-reported need for medication and problematic opioid use by nearly 50% as compared to controls.

“The myStrength platform helps people learn tools to improve their pain functioning, and also results in less reported medication usage and dependence,” said Dr. Abigail Hirsch, myStrength’s Chief Clinical Officer. “This work is so encouraging. We desperately need highly scalable options to bring quality behavioral health resources to primary care, emergency departments and other settings on the front lines of treating chronic pain and managing downstream impacts of opioids and other substances. This provides evidence-based support for adding myStrength’s digital behavioral self-care to chronic pain management protocols.”

About myStrength
myStrength, Inc. is a recognized leader in digital behavioral health. myStrength greatly enhances traditional care models, while addressing issues of cost, lack of access, and stigma, to deliver mental health and well-being resources at scale. Grounded in evidence-based approaches, our platform targets the most prevalent and costly behavioral health conditions ─ empowering consumers with innovative self-care resources to manage and overcome challenges with depression, anxiety, stress, substance use disorders, chronic pain and sleep. myStrength collaborates with more than 100 health plans, integrated health systems, EAPs, disease management providers, managed and community behavioral health providers, strategic alliances, ACOs and FQHCs. For more information, visit www.myStrength.com. To schedule a demo, please contact www.mystrength.com/contact

1 https://healthcare.mckinsey.com/why-we-need-bolder-action-combat-opioid-epidemic

Rebecca McIlwaine
+1 303-517-2601
email us here
Visit us on social media:

Source: EIN Presswire

New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest

Bacteria found in brains further proof that a microbe may trigger the disease

Bacteria in brain samples of people with Alzheimer's was found by a U.S. scientist is further proof that a microbe may trigger the disease.

These unexpected brain bacteria add urgency to Alzheimer's infection research.”

— Dr. Leslie Norins

NAPLES, FL, UNITED STATES, November 14, 2018 /EINPresswire.com/ — “The suspects have been reliably placed at the crime scene,” says Leslie Norins, MD, PhD, analyzing the accumulated evidence that microbes inhabit or visit the brain and likely trigger Alzheimer’s disease. Dr. Norins is CEO of Alzheimer’s Germ Quest, Inc., an independent advocacy group for Alzheimer’s research.

“The clincher,” he says, is the research presented by Rosalinda Roberts at the recent Society for Neuroscience meeting, and as featured in Science. She and colleagues at the University of Alabama, using electron microscopy, unexpectedly found bacterial forms penetrating and inhabiting brain tissue samples from healthy human brains. Similar evidence was found in samples from patients with schizophrenia, which was the disease they were studying.

The research found the “surprise” bacteria were “abundant” in the hippocampus, and substantia nigra, two brain areas also critical to both Alzheimer’s and Parkinson’s diseases.

Dr. Norins says Roberts’ findings of bacteria where they were unexpected immediately brought to his mind the discovery by Marshall and Warren of previously overlooked H. pylori bacteria inhabiting the stomach lining—from where they could cause gastric ulcers in some people.

Dr. Norins says this adds to the convincing evidence he heard at a recent Swiss conference, where leading researchers added to accumulating information indicating that one or more infectious agents could trigger Alzheimer’s.

“This pretty much wraps it up,” he says. “Microorganisms of all sorts live in or visit the brain. Now the major mystery is what makes the killer ones actually pull the trigger.”

Dr. Norins says this will require the National Institutes of Health and Alzheimer’s advocacy organizations to prioritize funding of the necessary research on Alzheimer’s infectious agents, instead of allocating most of their funds to traditional studies of brain proteins amyloid and tau.

He says, “If these infection leads prove fruitful, we could get a simple blood test for Alzheimer’s, an antibiotic to treat it, and even a preventive vaccine. There’s no downside, as whatever is found will be important new knowledge about the brain and its microbiome.”

Alzheimer’s Germ Quest, Inc. is a public benefit corporation headquartered in Naples, Florida. It sponsors a $1 million challenge award for the researcher who proves an infectious agent is the root cause of Alzheimer’s disease.

Mollie Page
Alzheimer's Germ Quest
+1 2397777243
email us here

Source: EIN Presswire

Think Silicon Completes Ambitious 2.5 Year Plan with the Successful Finalization of the EU Funded GPU-WEAR Project

This worthwhile effort required a multidisciplinary design methodology spanning circuits, architectural, compiler, and API-level power efficient techniques to work in a seamless fashion.”

— Dr. Georgios Keramidas CSO of Think Silicon and GPU-WEAR project lead

PATRAS, GREECE, November 15, 2018 /EINPresswire.com/ — Think Silicon, a leader in ultra-low power graphics IP technology, announced the completion of an ambitious 2.5 year plan with the culmination of an array of innovative ultra-low power Graphics-Processing-Unit (GPU) IP-technology, together with a complete ecosystem of development-tools. Key highlights for the company include filing 10 international patents (six granted, four pending) and extending the sales channel in Europe, North America, Taiwan and Japan. The impressive project goals, established in 2015, resulted in numerous exhibits at major trade events such as the International Consumer Electronics Show, Mobile World Congress, Embedded World and executive speaking opportunities at the Synopsys ARC Processor Summit, Linley Processor Conference 2017, HiPEAC 2018, DATE Conference, and many more.

“To reach a meaningful impact-level of ultra-low power consumption, required by Wearable, IoT and Embedded Display devices, represents a technological challenge”, says Dr. Georgios Keramidas CSO of Think Silicon and GPU-WEAR project lead. “This worthwhile effort required a multidisciplinary design methodology spanning circuits, architectural, compiler, and API-level power efficient techniques to work in a seamless fashion. We are very thankful for the support of the European Union’s ‘Horizon 2020’ Research and Innovation Programme.”

During the Horizon 2020 program, Think Silicon achieved a variety of technology achievements including:
● Holistic power reduction techniques
The main objective of the project was to develop holistic power reduction techniques by reducing power not only on ASICs (Chip) level, but also for the entire system (Display device). To achieve this, the company developed and implemented multiple techniques, such as value- memorization, new image/texture/z-buffer compression methods, smart clock gating, power gating, and adaptive backlighting.

● Transparent “display-aware” and “QoS-aware” graphics libraries
One of the biggest challenges that graphics application developers face is the lag of transparency accessing graphics libraries. Think Silicon implemented a “Run-time system” in the GPU driver as well as a QoS (Quality-of-Service) extension to graphics APIs. In addition, the cross-platform middleware GLOVE™ has been developed, which translates at runtime, OpenGL® ES / EGL calls and ESSL shaders to Vulkan® commands and SPIR-V Shader.

As an essential toolbox for developers to develop power-aware yet still high-performance software applications for Wearable, IoT and Embedded display devices, NEMA®|SDK is a complete ecosystem of tools providing the utmost access to the GPU hardware. The NEMA®|SDK tool-box is comprised of six tools: NEMA®|GFX-API, NEMA®|GUI-Builder, NEMA®|Bits, NEMA®|PIX-Presso, NEMA®|SHADER-Edit and GLOVE™.

● Heterogeneous GPU
NEMA®|tS (tiny-small) helps to achieve an optimal combination of power-performance load balancing.

Because Machine Learning and Deep Neural Networks (DNN) are complexity intensive models that require vast processing power, NEMA®|xNN was developed to address the 1000x gap (in terms of power and/or performance) compared to what competitive solutions offer.

Think Silicon has been recognized by global news outlets including Electronics Weekly, Packt, Microcontroller Tips, Programmable Web, the prestigious John Peddie Research and many more. Additional news about Think Silicon is available online at https://think-silicon.com/category/news/.

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 717850.

About Think Silicon:
Think Silicon S.A. is a privately held Limited Company located in: Patras/ Greece (HQ), Toronto/ Canada (Business Development & Marketing office), San Jose/CA, USA (Sales office), Cologne, Germany/EMEA region (Sales office), Taipei/TW (Sales office), Tokyo/JP (Sales office). Think Silicon is specialized in developing and licensing high-performance graphics and AI IP technology for ultra-low power and area limited digital mobile, wearable, embedded devices and IoT end-nodes for fabless semiconductor technology customers.
THINK SILICON, GLOVE and NEMA and combinations thereof, are registered trademarks of Think Silicon. Other names are for informational purposes only and may be trademarks of their respective owners.
Khronos™, EGL and Vulkan are trademarks or registered trademarks of The Khronos Group Inc. OpenGL is a registered trademark and the OpenGL ES logo are trademarks of Hewlett Packard Enterprise used under license by Khronos.

Georgia Protogerou
Think Silicon S.A.
email us here

Source: EIN Presswire

Ongoing Thigh Pain: Experts Recommend Early Sling Revision

Dr. Greg Vigna

Dr. Greg Vigna

Thigh and groin pain after placement of TOT vaginal mesh ‘sling’ continues as the primary source of morbidity for women who undergo ‘sling’ placement for SUI.

Injured women now have resources available to understand treatment options available for mesh related complications. Unfortunately, TOT slings and mini-slings continue to be implanted.”

— Dr. Greg Vigna

MODESTO, CALIFORNIA, UNITED STATES, November 14, 2018 /EINPresswire.com/ — Ongoing Thigh Pain: Experts Recommend Early Sling Revision

Thigh pain and groin pain after placement of transobturator tape (TOT) vaginal mesh ‘sling’ continues as the primary source of morbidity for women who undergo ‘sling’ placement for stress urinary incontinence (SUI). The source of chronic pain may be either direct muscle damage in the thigh (myofascial pain) or nerve damage (obturator neuralgia and/or pudendal neuralgia) caused by the polypropylene arms of the sling.

Manufacturers of the TOT ‘slings’ have kept these devices on the market despite the growing medical literature and FDA reported complaints of unacceptable risk of significant disabling pain associated with these devices. A few of the various TOT sling devices have been voluntarily removed from the market by their manufacturers, but unfortunately a majority of these devices remain as they market ‘mini-slings’ to physicians with shorter polypropylene arms that don’t pass into the thigh with hopes that these smaller slings would not cause the above crippling diagnoses.

Unfortunately, ‘mini-slings’ like their predecessors (TOT slings) continue to cause catastrophic pain syndromes including obturator neuralgia, pudendal neuralgia, and complex regional pain syndrome that cause disabling life-time pain syndromes that require costly ongoing medical care including medication management, pelvic floor physical therapy, Botox Injections, mesh revision surgery, and implantable nerve stimulators.

The American Urogynecologic Society (AUGS) has done little to publish best practice standards for clinicians who implant these devices with patients with persistent post-operative thigh pain despite published opinions by leaders such as Dr. Steven Petrou who recommends ‘that the rapid appearance of pain after the placement of a suburethral tape should embolden the surgeon to promptly proceed with removal prior to the period of tissue ingrowth’ into the sling arms. (Source: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000600028)

Fortunately, the standard of care for dealing with thigh pain, groin pain, painful intercourse (dyspareunia) after TOT or mini-sling implantation is early removal of these devices. Timely referral is now the standard of care to trained physicians in vaginal mesh revision surgery as a new generation of physicians have obtained the necessary training during their residencies to diagnose and treat the catastrophic pain syndromes associated with the TOT and mini-sling devices used for SUI.

Dr. Greg Vigna, a physician and national pharmaceutical injury attorney, states, “much has changed over the past 10 years. Injured women now have resources available to understand treatment options available for mesh related complications. Unfortunately, TOT slings and mini-slings continue to be implanted.”

For more information on pudendal neuralgia, obturator neuralgia, and complex region pain syndrome, go to http://pudendalportal.lifecare123.com.

Download the free eBook provided by Dr. Vigna and Dr. Michael Hibner by going to http://tvm.lifecare123.com/page/e-book.html or see an interview by Dr. Greg Vigna with Dr. Michael Hibner on treatment protocol for chronic pelvic pain: http://hibner.phaktory.net/video/65674772

Dr. Greg Vigna is a practicing physician, a national pharmaceutical injury attorney, and Certified Life Care Planner.

Greg Vigna
Greg Vigna, M.D., J.D.
+1 800-761-9206
email us here

Source: EIN Presswire

5th Annual Four Generations Leadership Awards

Becoming a Leader by Empowering Ourselves, and Others

One attendee last year observed that ‘It is so uplifting and encouraging to be in a room full of energetic and optimistic people. The awardees were amazing….’”

— Janine Finnell, Executive Director, Leaders in Energy

ARLINGTON, VIRGINIA, USA, November 14, 2018 /EINPresswire.com/ — Leaders in Energy (LE) is a community of engaged leaders advancing solutions for a sustainable energy system, economy, and world. We are a not-for-profit organization based in Washington with a worldwide membership.

Join LE for an evening of inspiration and comradery at its 5th annual Four Generations of Leaders in Clean Energy & Sustainable Solutions Awards and Holiday celebration. We will feature leaders from each of the four generations, e.g., World War II, Baby Boomer, Gen X, and Millennial who are boldly empowering themselves and others to create a better and greener world. Their diverse initiatives include broad-based vision, and empowering action at the local, state, and international levels ─ and span the fields of energy storage technology, environmental justice, energy education, and ecological and steady-state economics.

Our awardees are:

• Millennial Generation, Lindsey R. Shaw: Commercial Energy Program Manager, Montgomery County Department of Environmental Protection.
• Gen X Generation, Stephen Coughlin: President and Chief Executive Officer, Fluence, a joint venture between AES and Siemens.
• Baby Boomer Generation, Queen Zakia Shabazz: Coordinator of the Virginia Environmental Justice (EJ) Collaborative, a network of environmental organizations.
• World War II Generation, Dr. Herman Daly: Emeritus Professor at the University of Maryland's School of Public Policy and former Senior Economist in the Environment Department at the World Bank.

Learn more about our remarkable honorees and how they can inspire us all.

When and Where:
Friday, November 30th, 6:00 – 9:00 pm, at the Crystal Gateway Condo Complex, 1300 Crystal Drive, Arlington, VA 22202.

There are numerous alarming lists of concerns impacting the critical life support systems of our planet. Many of these pertain to how we produce and consume energy. At the same time, there are great opportunities to harness our ingenuity and imagination to utilize innovative technology and policy solutions. Hear our remarkable honorees on how they are working to make a difference. Enjoy food and drink in a festive atmosphere ─ and spend the evening with other like-minded people who are passionate about these issues and are working for change at individual and collective levels.

Registration: https://leadersinenergy.org/2018-four-gen-awards-and-holiday-event-november-30/ Tickets are also available for early bird (through November 22, 2018) and student pricing. Buy two tickets and get the 2nd ticket half price.

Janine Finnell
Leaders in Energy
+1 703-203-0766
email us here
Visit us on social media:

Source: EIN Presswire

The Pacific Mesothelioma Center Raises Over $143,000 for Mesothelioma Research at Annual 5K Walk for Meso!

The Pacific Mesothelioma Center raises mesothelioma awareness and funds for it's innovative mesothelioma research at annual 5K Walk for Meso.

LOS ANGELES, CA, UNITED STATES, November 14, 2018 /EINPresswire.com/ — The Pacific Mesothelioma Center at the Pacific Heart, Lung & Blood Institute marked its 7th annual 5K Walk/Hike for Mesothelioma on Oct 21, 2018, at the Paramount Ranch. With over 350 walkers, the event raised over $143,000 for malignant pleural mesothelioma research.

The 5K walk for mesothelioma plays a special role to many people for different reasons. For some, it offers them hope, that someday soon there will be better treatment options for this devastating disease. For others it offers them comfort, it reminds them of a family member or friend who died of mesothelioma too soon. And for mesothelioma warriors, who are able to see other warriors like themselves at the walk, it reminds them to keep up the fight.

Walkers arrived at The Paramount Ranch at around 9 AM and after receiving a complimentary T-shirt, and fruit products generously donated by Dole set out on the 5K or 1-mile hike.

After the walk, participants enjoyed a catered lunch by local Agoura Hills favorite Italia Deli, music by DJ Drew Young, and a program led by Master of Ceremonies CHiPS star Larry Wilcox. The live auction featured items such as a photo safari for two in South Africa and a Four Seasons Hotel luxury package. The opportunity drawing featured items such as gift baskets, dining and adventure certificates, and weekend getaways.

Many attendees walk to honor those they have lost to this devastating disease. Returning walker Delia states "I attended the walk to honor my late husband Sal, who courageously battled mesothelioma and sadly lost the fight this past March. I found the walk emotional and at the same time cathartic as it gave me hope that the money raised for research would one day find a cure. There are so very little research funds given to rare, aggressive and deadly cancers like mesothelioma.”

Lisa, a first-time walk attendee shared ” I organized Team Bruce for the walk to honor my dad Bruce Frederiksen who lost his battle earlier this year and to show support for everyone else whose lives have been devastated by this horrible disease. It was an emotionally charged day but I was so proud of the increased awareness this event brought to our cause and I'm thrilled about our successful fundraising for the research that will one day lead to a cure”.

The walk also brings together mesothelioma warriors including two-year mesothelioma survivor Tina who shared with us ”I keep telling my family that there are two fighters in this fight, me and mesothelioma and there’s only going to be one winner, and I’m going to be the winner”.

Donations for the 5K Walk for Mesothelioma are still being accepted at www.phlbi.org/5k-walk-for-mesothelioma.

About the PMC: Established in 2002, the Pacific Heart, Lung & Blood Institute (PHLBI) is a 501(c)(3) non-profit organization. The Pacific Mesothelioma Center (PMC), a division of the PHLBI, is focused on the treatment and prevention of malignant pleural mesothelioma, a rare form of cancer caused by asbestos exposure. The PMC serves a growing number of mesothelioma victims by supporting the nation’s first-of-its-kind research lab which provides laboratory-to-the-bedside research that improves mesothelioma victims’ lives and longevity. www.pacificmesotheliomacenter.org

Clare Cameron
The Pacific Heart, Lung & Blood Institute
+1 310-478-4678
email us here
Visit us on social media:

Source: EIN Presswire

Coronary Calcium Levels a Better Predictor of Risk for Coronary Heart Disease, Study Finds

A new study presented at the American Heart Association Scientific Session conference found that testing a patient’s coronary calcium levels is a better predictor of blocked coronary arteries for patients at risk for a heart attack.

New study finds that testing a patient’s coronary calcium levels is a better predictor of blocked coronary arteries for patients at risk for a heart attack.

Calcium in the artery doesn’t tell you the extent of soft plaque, but it does mark that disease is present. These results tell us that coronary calcium adds importantly to probability estimates.”

— Dr. Jeffrey L. Anderson, Intermountain Medical Center Heart Institute

SALT LAKE CITY, UT, USA, November 14, 2018 /EINPresswire.com/ — A new study presented at the American Heart Association Scientific Session conference found that testing a patient’s coronary calcium levels is a better predictor of blocked coronary arteries at risk for a heart attack and the need for revascularization than standard risk-assessment equations used in medical practice today.

“With coronary calcium, we’re looking at a marker indicating the actual presence of anatomic disease — we’re not just looking at probabilities of disease based on a patient’s standard risk factors,” said Jeffrey L. Anderson, MD, a cardiologist and cardiovascular researcher at the Intermountain Medical Center Heart Institute in Salt Lake City. “The risk factors are worth knowing, but they don’t tell whether or not you actually have the disease.”

Cardiovascular disease remains the greatest cause of morbidity and mortality in the United States, and determining who’s most at risk continues to be suboptimal, said Dr. Anderson.

Two-thirds of Americans with cardiovascular disease come from the very large, and what’s traditionally been considered the low-risk portion of the population based on standard risk factors, which means a lot of at-risk people are missed during screenings.

In the new study, researchers at the Intermountain Medical Center Heart Institute, which is part of the Intermountain Healthcare system, identified 1,107 symptomatic patients who presented to the healthcare system without any known coronary artery disease and who had a PET-stress test to measure coronary flow, conducted as part of their diagnostic evaluation.

The PET/CT test also enabled a coronary calcium score to be measured. Based on the coronary calcium score and standard risk factors documented in their medical records, three different atherosclerotic cardiovascular disease risk scores were calculated: the standard Pooled Cohort Equation (based on traditional risk factors), the Multi-Ethnic Study of Atherosclerosis (MESA) Risk Score (which combines coronary calcium and traditional risk factors), and the Coronary Calcium Score alone

Researchers tracked those patients to identify who, based on PET scan results suggesting a blocked artery, went on to revascularization (a coronary stent or bypass surgery) and who had a subsequent heart attack or died during the subsequent two years.

They found that risk equations that included coronary artery calcium measurements, i.e., the MESA Score and the Coronary Calcium Risk Score, were better able to predict the presence of symptomatic coronary artery disease requiring revascularization than the Pooled Cohort Equation, which relies only on standard risk factors such as age, gender, blood pressure, and cholesterol measurements.

However, after the PET-scan results were acted upon, all three equations were only moderately successful in determining who over two years of follow-up would go on to die or have a heart attack. Noteworthy though was that of the 29 patients who showed no coronary artery calcium, none had any major heart problems in the time-period tracked.

Researchers presented results from the study at the American Heart Association’s 2018 Scientific Session in Chicago.

“Calcium in the artery doesn’t tell you the extent of soft plaque, but it does mark that disease is present,” Dr. Anderson said. “These results tell us that coronary calcium adds importantly to probability estimates.”

He also said the cost of coronary calcium screening is low, in the range of $100 or less, and should be considered in the future as part of routine medical care after age 50 for men and 55-60 for women.

“We accept that mammograms should be done for women and colonoscopies should be done for everybody at a certain age, and they’re much more expensive than a calcium scan,” he said.

Dr. Anderson hopes the findings lead to coronary calcium tests becoming more accepted and covered by medical insurance as a means to better predict who is at coronary risk, which not only will get high-risk patients into treatment earlier, but also keep patients who aren’t truly at risk from being overtreated.


Jess Gomez
Intermountain Medical Center
email us here

Source: EIN Presswire